Tenofovir Disoproxil Fumarate
Tenofovir Disoproxil Fumarate is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Tenofovir Disoproxil Fumarate; Generic name: TENOFOVIR DISOPROXIL FUMARATE; Manufacturer: PD-Rx Pharmaceuticals, Inc..
| Brand name | Tenofovir Disoproxil Fumarate |
|---|---|
| Generic name | TENOFOVIR DISOPROXIL FUMARATE |
| Manufacturer | PD-Rx Pharmaceuticals, Inc. |
| Used for | 1 INDICATIONS & USAGE Tenofovir disoproxil fumarate tablets are a nucleotide analog HIV-1 reverse transcriptase inhibitor and an HBV reverse transcriptase inhibitor. • Tenofovir disoproxil fumarate tablets are indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients 2 years of age and older. (1) • Tenofovir disoproxil fumarate tablets are indicated for the treatment of chronic hepatitis B in adults and pediatric patients 12 years of age and older. (1) 1.1 HIV-1 Infection Tenofovir disoproxil fumarate tablets are indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pe |
| Dosage | 2 DOSAGE & ADMINISTRATION • Recommended dose for the treatment of HIV-1 or chronic hepatitis B in adults and pediatric patients 12 years of age and older (35 kg or more): 300 mg once daily taken orally without regard to food. (2.1) • Recommended dose for the treatment of HIV-1 in pediatric patients (2 to less than 12 years of age): o Tablets: For pediatric patients weighing greater than or equal to 17 kg who can swallow an intact tablet, one tenofovir disoproxil fumarate tablet (300 mg based on |
| Warnings | BOXED WARNING WARNING: POSTTREATMENT EXACERBATION OF HEPATITIS Severe acute exacerbations of hepatitis have been reported in HBV-infected patients who have discontinued anti-hepatitis B therapy, including tenofovir disoproxil fumarate tablets. Hepatic function should be monitored closely with both clinical and laboratory follow-up for at least several months in patients who discontinue anti-hepatitis B therapy, including tenofovir disoproxil fumarate tablets. If appropriate, resumption of anti-h |
| Active ingredient(s) | TENOFOVIR DISOPROXIL FUMARATE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=08a30772-02fc-4f63-e063-6394a90afd43 |